Cas:176324-60-0 tert-butyl 2-ethenylpyrrolidine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 2-ethenylpyrrolidine-1-carboxylate

CAS.NO:176324-60-0

Synonyms:2-(R)-Vinyl-pyrrolidine-1-carboxylic Acid Tert-Butyl Ester;N-Boc-2-vinylpyrrolidine;2-Vinyl-pyrrolidine-1-carboxylic ac;tert-butyl 2-vinylpyrrolidine-1-carboxylate;N-(tert-butoxylcarbonyl)-2-vinylpyrrolidine;N-(tert-butoxycarbonyl)-2-vinylpyrrolidine;N-(tert-butyloxycarbonyl)-2-vinylpyrrolidine

Molecular Formula:C₁₁H₁₉NO₂

Molecular Weight:197.27400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.54000

Exact Mass:197.14200

LogP:2.50980

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(R)-Vinyl-pyrrolidine-1-carboxylic Acid Tert-Butyl Ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(tert-butyloxycarbonyl)-2-vinylpyrrolidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(tert-butoxylcarbonyl)-2-vinylpyrrolidine Use and application,N-(tert-butyloxycarbonyl)-2-vinylpyrrolidine technical grade,usp/ep/jp grade.

Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. tert-butyl 2-ethenylpyrrolidine-1-carboxylate manufacturer Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. tert-butyl 2-ethenylpyrrolidine-1-carboxylate supplier Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. tert-butyl 2-ethenylpyrrolidine-1-carboxylate vendor Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. tert-butyl 2-ethenylpyrrolidine-1-carboxylate factory The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.